The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Type 1 Diabetes Market Research Report 2024
Synopsis
The global Type 1 Diabetes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Type 1 Diabetes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Type 1 Diabetes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Type 1 Diabetes in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Type 1 Diabetes include Abbott, Bayer, Eli Lilly, BD, Johnson & Johnson, Merck, Pfizer, AstraZeneca and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Type 1 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 1 Diabetes.
Report Scope
The Type 1 Diabetes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 1 Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 1 Diabetes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche
Smiths Medical
Medtronic
Segment by Type
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs
Segment by Application
Hospitals
Diagnostic clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 1 Diabetes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Type 1 Diabetes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Type 1 Diabetes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Type 1 Diabetes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Type 1 Diabetes in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Type 1 Diabetes include Abbott, Bayer, Eli Lilly, BD, Johnson & Johnson, Merck, Pfizer, AstraZeneca and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Type 1 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 1 Diabetes.
Report Scope
The Type 1 Diabetes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 1 Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Type 1 Diabetes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche
Smiths Medical
Medtronic
Segment by Type
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs
Segment by Application
Hospitals
Diagnostic clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 1 Diabetes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rapid Acting Insulin Analogs
1.2.3 Long Acting Insulin Analogs
1.2.4 Premix Insulin Analogs
1.3 Market by Application
1.3.1 Global Type 1 Diabetes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Type 1 Diabetes Market Perspective (2019-2030)
2.2 Type 1 Diabetes Growth Trends by Region
2.2.1 Global Type 1 Diabetes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Type 1 Diabetes Historic Market Size by Region (2019-2024)
2.2.3 Type 1 Diabetes Forecasted Market Size by Region (2025-2030)
2.3 Type 1 Diabetes Market Dynamics
2.3.1 Type 1 Diabetes Industry Trends
2.3.2 Type 1 Diabetes Market Drivers
2.3.3 Type 1 Diabetes Market Challenges
2.3.4 Type 1 Diabetes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type 1 Diabetes Players by Revenue
3.1.1 Global Top Type 1 Diabetes Players by Revenue (2019-2024)
3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2019-2024)
3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type 1 Diabetes Revenue
3.4 Global Type 1 Diabetes Market Concentration Ratio
3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2023
3.5 Type 1 Diabetes Key Players Head office and Area Served
3.6 Key Players Type 1 Diabetes Product Solution and Service
3.7 Date of Enter into Type 1 Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type 1 Diabetes Breakdown Data by Type
4.1 Global Type 1 Diabetes Historic Market Size by Type (2019-2024)
4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2025-2030)
5 Type 1 Diabetes Breakdown Data by Application
5.1 Global Type 1 Diabetes Historic Market Size by Application (2019-2024)
5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Type 1 Diabetes Market Size (2019-2030)
6.2 North America Type 1 Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Type 1 Diabetes Market Size by Country (2019-2024)
6.4 North America Type 1 Diabetes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Type 1 Diabetes Market Size (2019-2030)
7.2 Europe Type 1 Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Type 1 Diabetes Market Size by Country (2019-2024)
7.4 Europe Type 1 Diabetes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type 1 Diabetes Market Size (2019-2030)
8.2 Asia-Pacific Type 1 Diabetes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Type 1 Diabetes Market Size by Region (2019-2024)
8.4 Asia-Pacific Type 1 Diabetes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Type 1 Diabetes Market Size (2019-2030)
9.2 Latin America Type 1 Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Type 1 Diabetes Market Size by Country (2019-2024)
9.4 Latin America Type 1 Diabetes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type 1 Diabetes Market Size (2019-2030)
10.2 Middle East & Africa Type 1 Diabetes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Type 1 Diabetes Market Size by Country (2019-2024)
10.4 Middle East & Africa Type 1 Diabetes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Type 1 Diabetes Introduction
11.1.4 Abbott Revenue in Type 1 Diabetes Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Type 1 Diabetes Introduction
11.2.4 Bayer Revenue in Type 1 Diabetes Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type 1 Diabetes Introduction
11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Type 1 Diabetes Introduction
11.4.4 BD Revenue in Type 1 Diabetes Business (2019-2024)
11.4.5 BD Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Type 1 Diabetes Introduction
11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Type 1 Diabetes Introduction
11.6.4 Merck Revenue in Type 1 Diabetes Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Type 1 Diabetes Introduction
11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Type 1 Diabetes Introduction
11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche Type 1 Diabetes Introduction
11.9.4 Roche Revenue in Type 1 Diabetes Business (2019-2024)
11.9.5 Roche Recent Development
11.10 Smiths Medical
11.10.1 Smiths Medical Company Detail
11.10.2 Smiths Medical Business Overview
11.10.3 Smiths Medical Type 1 Diabetes Introduction
11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2019-2024)
11.10.5 Smiths Medical Recent Development
11.11 Medtronic
11.11.1 Medtronic Company Detail
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Type 1 Diabetes Introduction
11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2019-2024)
11.11.5 Medtronic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
